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PREVIOUS investigations included experiments involving subcutaneous injec-
tion of the large dose of 05 mg. of 9:10-dimethyl-1:2-benzanthracene into the
flank and below a nipple in strain Street mice (Rask-Nielsen, 1948). In both
sites the injection induced only spindle-cell sarcomas and, in a few instances,
squamous-cell carcinomas, but no mammary carcinomas. At the same time a
marked development of leukaemia was observed, the leukaemic manifestations
varying according to the site ofinjection. The ratio of cases of isolated thymic
tumours to cases ofgeneralized leukaemia was found to be 1: 1 following injection
into the flank and 1: 5 following injection into the mammary region. Renewed
experiments with subcutaneous injections of 05 mg. of 9:10-dimethyl-1:2-ben-
zanthracene were performed. The leukaemic manifestations induced have been
described in detail in a recent publication (Rask-Nielsen, 1949) and the local
tumours will be dealt with in the present paper.
For the purpose of ascertaining whether the failing development of mammary
carcinoma might be a phenomenon specific for injection of 9:10-dimethyl-1:2-
benzanthracene, mice ofstrain Street were injected with 05 mg. of3:4-benzpyrene,
1:2:5:6-dibenzanthracene, and 20:methylcholanthrene, into the mammary region.
In an endeavour to find out also whether injection of these three hydro-
carbons would induce equally marked development of luekaemia and whether
the leukaemic lesions would differ in the same way as following injection of
9:10-dimethyl-1:2-benzanthracene, into the two sites, the three hydrocarbons, in
doses of05 mg., were injected subcutaneously in the flank as well. These experi-
ments will be reported in the present paper which also includes the earlier experi-
ments with 9:10-dimethyl-1:2-benzanthracene (Rask-Nielsen, 1948, 1949) for
comparison.
MATERIALS AND METHODS.
Benzpyrene, dibenzanthracene or methylcholanthrene, 0.5 mg., was injected,
suspended in 0-01 c.c. of a mixture ofthe same hard and liquid paraffin as used in
the analogous experiments with 9:10-dimethyl-1:2-benzanthracene (Rask-Nielsen,
1948, 1949). As regards the two last-mentioned hydrocarbons, the same sus-
pension was used for injection into the flank and into the mammary region,
whereas a new suspension of benzpyrene had to be prepared from a new batch
of benzpyrene for the injection into the mammary tissue.
The carcinogenic agents were injected into the left flank or below the second
lowest nipple on the right side.LOCAL AND REMOTE TUMOURS
The mice used were of strain Street, ranging in age from 4 to 7 weeks. An
equal number of females and males were injected into the flank, but only female
mice were injected into the mammary region, except in a few 9:10-dimethyl-1:2-
benzanthracene experiments, where an equal number of each sex was used.
More than half the experiments were carried out with litter mates, one half
ofeach litter being left untreated as a control group. The remaining experiments
were carried out without controls. Table I sets out the spontaneous tumours
TABLE J.-Tumours Observed in the Controls.
Incidence. Age in months.
Leukaemia . . . . 4/302,1-3% . 6, 8, 9, 14
Mammary carcinomas in non-
breeding females . . . 12/134, 8.7% . 10, 16, 16, 17, 17, 18, 18, 19, 23, 24, 25, 26
Pulmonary adenomas . . . 7/143, 5% . ll, 16, 16, 17, 25, 25, 27
Subcutaneous sarcoma . . 1/22, 5% . 23
observed in all the controls. It will be seen that the incidence ofleukaemia was
13 per cent, of mammary carcinoma in non-breeding females 8 7 per cent, of
pulmonary adenoma 5 per cent, and of subcutaneous sarcoma 5 per cent. These
figures are in-fair accordance with previous findings of spontaneous tumours in
Street mice (Rask-Nielsen, 1948, 1949; Lef6vre, 1945).
II.
RESULTS.
The number and survival time ofthe experimental mice arepresented in Table
TABLE II.-Number and Survival Time of Experimental Mice.
Site of
injection. Injection of0.5 mg.
Benzpyrene
Dibenzanthracene
Flank Methylcholanthrene 9:10-Dimethyl-1:2-benzan-
thracene
rBenzpyrene
Mammary Dibenzanthracene ary Methylcholanthrene region. 9:10-Dimethyl-1:2-benzan-
. thracene
3. 6.
63 . 36
43 . 34
57 . 27
. 306 .
. 58 .
. 53 .
. 60 .
152
38
17
33
9.
27
26
9
44
15
17
13
Months.
12. 15. 18. 21. 24. 27.
17 . 12 . 9 . 3 . 3 . 2 .
13 . 5 . . 0 . . .
4 . 4 . 3 . 2 -. I . I .
20
7
9
5
2
5
6
0
1
4
4
. 0 .
4.
. 2.
1
2
. 345 . 164 . 40 . 12 . 2 . 1. 0 .- . .-
Local tumours.
The local tumours were sarcomas and squamous-cell carcinomas as apparent
from Table III. 'The former were of the ordinary type, usually spindle-cell
TABLE III.-Incidence of Local Tumours.
Injection of 0-5 mg.
Benzpyrene .
Fak Dibenzanthracene
Flank t Methylcholanthrene
9:10-bDimethyl-1:2-benzanthracene
Mammary Benzpyrene ay Dibenzanthracene
region. Methylcholanthrene
*9:10-Dimethyl-1:2-benzanthracene
Spindle-cell sarcomas.
Incidence. Age In months.
14/51, 27% . 4-12
18/36, 50% . 7-15
17/44, 39% . 5-9
26/222, 12% 4-10
2/54,4% . 8-10
11/50, 22% . 8-18
17/46, 37% . 5-11
21/254, 8.3% . 5-9
Squamous-cell carcinomas.
Incidence. Age in
3/51, 6% . 7-11
3/44,7/ 8-30
.2!222, 0.8% . 5-7
1/54,2% * 8
1/50,2% . 27
10/46, 22% . 4-13
.6/254, 2.4% . 4-8
30.
0
0 1
0
Site of
injection.
I
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sarcomas of a varying degree of differentiation; a few were polymorphocellular,
and a few rhabdomvosarcomas occurred. In the squamous-cell carcinomas
marked cornification was a frequent finding; no microscopic changes indicated
that the growths might have originated in mammary tissue. On the other hand,
3 mice, 8, 11 and 13 months of age, exhibited typical mammarv carcinomas in a
site which made it impossible to exclude local tumour production. In1 view ofthe
age of these mice. however, the growths were considered to be most probably
spontaneous and were, therefore, not included in Table III.
Following injection in the flank, spindle-cell sarcomas were induced by benz-
pyrene, dibenzanthracene, methylcholanthrene and 9:10-dimethyl-1:2-benzan-
thracene in 27 per cent, 50 per cent, 39 per cent and 12 per cent of the effective
total of mice respectively. Squamous-cell carcinomas were observed in the
same experiment in 6 per cent, 7 per cent and 0-8 per cent following the injection
of benzpyrene, methylcholanthrene and 9:10-dimethyl-1:2-benzanthracene respec-
tivelv. As regards the application into the mammary region, spindle-cell sar-
comas were observed following injection ofbenzpvrene, dibenzanthracene, methvl-
cholanthrene, and 9:10-dimethyl-1 :2-benzanthracene in 4 per cent, 22 per cent,
37 per cent and 8-3 per cent respectively. In this experiment, squamous-cell
carcinoma was observed in 2 per cent, 2 per cent, 22 per cent and 2-4 per cent
respectively. The effective total of experimental mice is the number of mice
living to be as old as the youngest tumour-bearing mouse, namely 4 months.
The minimum, maximum and average latent period, the interval from the
injection until death, is presented in Table IV. The average latent period of
TABLE J.-Minimumr. Maximum and Average Latent Period ofthe Local Tumours
(in tceeks).
Site of Spindle-cell sarcomas. Squamous-cell carcinomas. Stionf Injection of 0-5 mg. injection. Minimum. Maximum. Average. Minimum. Maximum. Average.
rBeflzp3rene. . . 15 . 59 . 32 . 27 . 46 . 35
D Dibenzanthracene . . 27 . 60 . 42 . -
Flank V Methylcholanthrene . 16 . 35 . 22 . 29 . 127 . 65
9:10-Dimetbyl-1:2-ben-
L zanthracene . . 14 . 34 . 21 . 20 . 23 . 21
rBenzpyrene. . . 29 . 38 . 33 . . . 34
I Dibenzanthracene. . 31 . 74 . 47 . - . - .101 'ammary Methylcholanthrene . 18 . 43 . 26 . 14 . 53 . 26 region i9:1O-Dimethy-1:2-ben-
zathracene . .13 .36 . 24 .11 28 .18
spindle-cell sarcoma proved to be longest following injection of dibenzanthracene
being 42 and 47 weeks following injection into the flank and the mammarv
region respectivelv. Following injection of benzpyrene, the latent periods were
32 and 33 weeks, following injection of methvlcholanthrene 22 and 26 weeks, and
following injection of 9:10-dimethyl-1:2-benzanthracene 21 and 24 weeks. Since
squamous-cell carcinoma developed in such small numbers, the duration of the
latent period is not applicable for deductions, but it appeared to be about the
same as that of the spindle-cell sarcomas.
The marked difference in the incidence of tumours following injection of
benzpyrene is presumablv due largely to the fact that two different suspensions
of the carcinogenic agent had to be used.
Considering the marked fluctuations in the incidence of new growths following
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injection of small as well as fairly large doses of hydrocarbon under experimlental
conditions as identical as possible (Leiter and Shear, 1943), the present imaterial
probably justifies only the following conclusions:
(1) Under the experimental conditions concerned, neither benzpyrene, diben-
zanthracene, methylcholanthrene, nor 9:10-dimethyl-1:2-benzanthracene was
able to induce mammary carcinoma.
(2) The incidence of local tumours increased following injection of 0.-5 nmg. of
the four hydrocarbons in the order: 9:10-dimethyl-1:2-benzanthracene, benz-
pyrene, dibenzanthracene, methylcholanthrene, and the latent period decreased in
the order: Dibenzanthracene, benzpyrene, methylcholanthrene, 9:10-dinmethyl-
1:2-benzanthracene. In other words, the orders of the incidence and of the
latent period of the tumours following injection of the four hydrocarbons wvere
not the same.
Remote tumours.
Since non-local tumours developed to the same extent following injection into
the flank and into the inanimary tissuie, the tunmours of both experiments are set
out together in Table V.
TABLE V. Incidence of Remote Tumours.
Leukaemia. Pulmonary adenomas. Granulosa-cell tuimours.
Injection of 0 5 mg. K - .'
Incidence. Age in Incidence. Age in Inicideince. Age in
months. months. moniths.
Benzpyrene . 7/105, 6.7% 4-21 . 1/74, 1-3% 25
Dibenzanthracene . 1/86, 1-2% 24 1/51, 2% 14
Methylcholanthrene . 0/90, - 3/60, 5° . 7-30
9:10-Dimethyl-1:2-
benzanthracene . 97/476, 20.4% . 4-14 . 9/316, 2-8% . 6-20 5/198, 2-5% 6-8
Leukaemia.- Leukaemia was observed following injection of benzpyrene,
dibenzanthracene and 9:10-dimethyl-1:2-benzanthracene in 6 7, 1 2 and 20 4
per cent of the effective total respectively. Injection of methylcholanthrene did
not induce leukaemia. The effective total is the number of experimental mice
living to be at least as old as the youngest mouse affected with leukaemia, namely
4 months.
Among the seven instances of leukaemia observed following injection of benz-
pyrene, two were isolated thymic lymphosarcomas occurring in mice aged 4 and
14 months. The remaining five cases, occurring in mice ranging in age from
14 to 21 months, were generalized leukaemias, characterized by an enlarged
liver and spleen showing pronounced leukaemic infiltrations. One of the latter
exhibited enlargement of the mesenteric lymph node; in the others the lymph
nodes were not enlarged. The average latent period of leukaemia was 63 weeks.
In six cases the infiltrations were due to stem cells and in one to plasma cells.
The only case of generalized leukaemia following injection of dibenzanthracene
was of the former variety in a 24-month-old mouse.
The leukaemias observed following injection of 9:10-dimethyl-1:2-benzan-
thracene and the relationship of the leukaemic manifestations to the site of
injection have been dealt with in a previous publication (Rask-Nielsen, 1949).
It is therefore sufficient to state here that injection of this hydrocarbon into
127R. RASK-NIELSEN
the flank induced thymic tumours in 13 per cent and generalized leukaemia in
5-6 per cent of the females, whereas injection into the mammary region induced
thyinic tumours in 4-3 per cent and generalized leukaemia in 20 per cent of the
females. In the males, no difference was apparent in the sites of the leukaemic
manifestations. It appears from Table V that the total incidence ofleukaemia
following injection of 9:10-dimethyl-1:2-benzanthracene into the flank and into
the mammary region was 20 4 per cent. The average latent period was 20 to
25 weeks (Rask-Nielsen, 1949).
The experiments thus go to show that the extensive and greatly accelerated
development of leukaemia observed following subcutaneous injection of 0 5 mg.
of 9:10-dimethyl-1:2-benzanthracene failed to appear following subcutaneous
injection of the same amount of benzpyrene, dibenzanthracene, or methylcholan-
threne. It is worth mentioning, however, that while dibenzanthracene and
methylcholanthrene had definitely no effect on the development of leukaemia,
it is impossible to rule out a faint, accelerating effect of benzpyrene, the incidence
of leukaemia being 6 7 per cent as compared with an incidence of spontaneous
leukaemia of1 to 2 per cent. This accelerating effect, if any, caused only a
slight increase in the incidence, but, unlike that following injection of 9:10-
dimnethyl-1:2-benzanthracene, no decrease in the latent period.
Pulmonary adenomas.-The study only includes macroscopic adenomas. In
most instances there were only a couple or a few ordinary, typical, subpleural
adenomas, about1 mm. in size and in a few cases one or two larger swellings,
2 to 5 mm. in diameter, were found. Microscopical examination showed typical
pulmonary adenomas sometimes with transitional stages to adenocarcinoma.
In four cases the pulmonary adenomas co-existed with spindle-cell sarcomas, in
two with leukaemia.
As apparent from Table V, pulmonary adenomas were observed following
injection ofbenzpyrene, dibenzanthracene, methylcholanthrene and 9:10-dimethyl
1:2-benzanthracene in1P3, 2, 5 and 2-8 per cent of mice respectively. Since the
incidence of spontaneous pulmonary adenoma among the controls was 5 per
cent (TableI) and since the incidence inprevious experiments (Rask-Nielsen, 1948,
1949; Lefevre, 1945) has been about the same, it is evident that injection of
benzpyrene,dibenzanthracene,methylcholanthrene, and9:10-dimethyl-1 :2-benzan-
thracene failed to increase the incidence of pulmonary adenomas, but injection
ofmethylcholanthrene and 9:10-dimethyl-1:2-benzanthracene appears to have
accelerated the development of these tumours. For instance, four of the 12
mice with pulmonary adenoma in these two groups succumbed before the first
control died with adenoma at the age of 11 months. It mnust be presumed,
moreover, that the apparently low incidence ofpulmonary adenomas is explicable
to some extent by the comparatively short survival time ofthe experimental mice.
Finally, it should be mentioned that five cases of granulosa-cell tuimours of
the ovary were noted in mice aged 6 to 8 months among 198 mice injected with
9:10-dimethyl-1:2-benzanthracene and living to be at least 6 months of age, an
incidence of 2-5 per cent. This type of tumour was not observed in anv case
following injection of the other three hydrocarbons.
On the whole, theexperiments showed that injection of benzpyrene, dibenzan-
thracene and methylcholanthrene induced almost exclusively local tumnours, the
incidence increasing in the order mentioned. Injection of 9:10-dimethyl-1:2-
benzanthracene did, indeed, induce a certain incidence of local tumours, but it
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resulted in a much higher increase in the development of remote tumours, par-
ticularly leukaemia.
Mammary carcinoma was not induced by any of the four hydrocarbons.
DISCUSSION.
Local tumours.
Injection of the four hydrocarbons used in the experiments failed to induce
mammary carcinomas. Previous attempts have given conflicting results. In-
jection of methylcholanthrene into certain strains of mice has induced these
growths (Bonser and Orr, 1939; Strong and Smith, 1939; Strong and Williams,
1941; Strong, 1945), whereas injection into other strains has been ineffective
(Strong and Smith, 1939; Esmarch, 1940a, 1940b). -Injection of 9:10-dimethyl-
1:2-benzanthracene has been reported to induce mammary carcinoma in one
strain (dilute brown), but not in another (AKA) (Engelbreth-Holm and Lefevre,
1941). Painting with methylcholanthrene has induced mammary carcinoma in
some strains ofmnice (Engelbreth-Holm, 1941; Lefevre, 1945: Mider and Morton,
1939a; Kirschbaum, Williams and Bittner, 1946), but not in strain Street
(Lefevre, 1945). Similarly, painting with 9:10-dimethyl-1:2-benzanthracene has
acceleratedthe development of mammary growths in several strains (Engelbreth-
Holm and Lefevre, 1941; Lefevre, 1945), but not in strain Street (Lefevre, 1945).
Apartfrom the presence ofthe milk agent and hormonal stimulation, theinduction
of mammary carcinoma, therefore, appears to depend more on the genetic con-
stitution of the mice used than on the hydrocarbon. As far as the development
of mammary carcinoma is concerned, Street mice appear to be refractory to
painting with methylcholanthrene and with 9:10-dimethyl-1:2-benzanthracene
as well as to injection of the four hydrocarbons used in the present experiments,
whereas they have been found to respond to the action of oestrogens (Rask-
Nielsen, 1948).
Some of the squamous-cell carcinomas observed in the present experiments
may perhaps have originated in mammary tissue, although the microscopic
architecture of the growths failed to indicate such an origin. If so, methyl-
cholanthrene would appear to be particularly active in this respect, since the
incidence of squamous-cell carcinoma following injection of this hydrocarbon
into the mammary region was no less than 22 per cent.
The relative carcinogenicity of the four hydrocarbons for subcutaneous tissue
estimated from the incidence of local tumours increased in the order, 9:10-di-
methyl-1:2-benzanthracene, benzpyrene, dibenzanthracene, methylcholanthrene
(Table III). Comparative experiments involving subcutaneous- injection of
9:10-dimethyl-1:2-benzanthracene and other hydrocarbons under identical experi-
mental conditions do not appear to have been published previously. In other
experiments 9:10-dimethyl-1:2-benzanthracene has induced only relatively few
subcutaneous growths (Shear, 1938; Engelbreth-Holm, 1939; Engelbreth-
Holm and Lefevre, 1941), a finding which is in keeping with the one reported in
the present paper.
The relative carcinogenicity of benzpyrene, dibenzanthracene, and methyl-
cholanthrene, on the other hand, was different from that usually reported (Green-
stein, 1947), the carcinogenicity of dibenzanthracene having been reported to be
lower than that of benzpyrene. In the present experiments the opposite order
9
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was found. This difference must presumably be ascribed to a difference in the
genetic constitution of the mice and possibly also to the vehicle used. The
higher carcinogenicity of methylcholanthrene than of the other hydrocarbons
apparent from the present experiments accords with previous findings (Greenstein,
1947). It accords also with the recent observation (Rask-Nielsen, 1950a) that
subcutaneous application of 0-02 mg. of this hydrocarbon to Street mice induced
local tumours in 10 per cent of the mice, whereas application of benzpyrene,
dibenzanthracene, or 9:10-dimethyl-1:2-benzanthracene, 0-02 mg., failed to induce
local growths. It is worth mentioning that the carcinogenicity of benzpyrene,
dibenzanthracene, and methylcholanthrene for the interstitial connective tissue
of the lung (Rask-Nielsen, 1950b), introduced directly into the lung in doses of
0 5 mg., increased in the same order as the carcinogenicity f6r subcutaneous con-
nective tissue, whereas 9:10-dimethyl-1:2-benzanthracene failed to induce local
spindle-cell sarcoma in the interstitial tissue of the lung. Accordingly, the con-
nective tissue of the lung in Street mice at least, appears to respond differently
to this hydrocarbon and to the other three agents. The order of carcinogenicity
of the three hydrocarbons for the thymus was the same as in the case of the
connectivetissue, whereasthe carcinogenicity of9:10-dimethyl-1:2-benzanthracene
for the thymus was practically the same as that of methylcholanthrene.
Remote t?umoutr8.
Table V shows that while injection of 0.5 mg. of 9:10-dimethyl-1:2-benzan-
thracene was followed by leukaemic manifestations in 20-4 per cent with an
average latent period of 20 to 25 weeks (Rask-Nielsen, 1949), injection of diben-
zanthracene and methylocholanthrene had no accelerating effect on the develop-
ment ofleukamia, and the doubtful, extremely faint acceleration observed follow-
ing injection ofbenzpyrene affected at any rate only the incidence; not the latent
period.
The absence of leukaemic lesions following injection of the three last-men-
tioned hydrocarbons is all the more remarkable, as the development of leukaemia
has been found to be accelerated following painting with benzyprene in dilute
brown mice (Morton and Mider, 1941) and in strain F mice (Kirschbaum and
Strong, 1942) following painting with dibenzanthracene, without, however,
decreasing the latent period in strain F mice and with methylcholanthrene in
strain F mice (Kirschbaum and Strong, 1942), in dilute brown mice (Mider and
Morton, 1939b; Morton and Mider, 1941; Lefevre, 1945), in strains Rf, and
Rf/Ak (McEndy, Boon and Furth, 1942), in C3H mice (Kirschbaum, Strong and
Gardner, 1940; Morton and Mider, 1941), and in old and new Buffalo mice
(Morton and Mider, 1941). Painting with 9:10-dimethyl-1:2-benzanthracene
also accelerated the development of leukaemia in AKA mice (Engelbreth-Holm
and Lefevre, 1941 ; Lefevre, 1945), in dilute brown mice (Engelbreth-Holm and
Lefevre, 1941; Law, 1941), and in Swiss mice (Law, 1941). No acceleration of
the development of leukaemia has, however, been obtained by methylcholan-
threne painting of C57 mice (Morton and Mider, 1941; Kirschbaum, Strong and
Gardner, 1940) and of CHI, NH, CBAN mice (Kirschbaum, Strong and Gardner,
1940), or by 9:10-dimethyl-1:2-benzanthracene painting of C3H, Leaden, ABC, N
and C57 mice (Law, 1941). Since painting, especially with methylcholanthrene,
has proved to accelerate the development of leukaemia in several experiments
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involving a number of different strains of mice, it seems strange that subcu-
taneous injection of this hydrocarbon had no remote effect, such as was observed
following injection of 9:10-dimethyl-1:2-benzanthracene.
It was, however, reported by Lefevre (1945) that the development ofleukaemia
in Street mice was accelerated only by painting with 9:10-dimethyl-1:2-benzan-
thracene and not by painting with methylcholanthrene. The difference in the
effect of the two hydrocarbons found in the present experiments may, therefore,
perhaps be ascribed to the genetic constitution of Street mice.
On the other hand, it is equally, if not more, probable that the difference in
the remote effect ofthese hydrocarbons is partially or wholly due to their different
solubilities and different rates of diffusion in the subcutaneous tissue. While
subcutaneous injection of 9:10-dimethyl-1:2-benzanthracene induced leukaemic
lesions in 20 per cent of the mice, the same dose of the hydrocarbon applied to
the pulmonary tissue was followed by no such manifestations (Rask-Nielsen,
1950b). This finding would appear to support the latter explanation.
Another fact pointing in the same direction is the fairly extensive develop-
ment ofleukaemia following subcutaneous injection of 9:10-dimethyl-1:2-benzan-
thracene into AKA mice (Engelbreth-Holm and Lefevre, 1941).
The same applies to the acceleration of granulosa-cell tumours noted in the
present experiments following injection of 9:10-dimethyl-1:2-benzanthracene as
compared with the failure of the other three hydrocarbons to accelerate this
variety ofgrowth.
The low incidence of pulmonary adenoma following subcutaneous injection
of 9:10-dimethyl-1:2-benzanthracene may presumably be ascribed to the short
survival time of the experimental mice (Table II). This explanation is also
indicated by the occurrence of an increased number ofadenomas in mice ranging
in age from 11 to 26 months following injection of 9:10-dimethyl-1:2-benzan-
thracene, 002 mg. into the lung (Rask-Nielsen, 1950a), and by the induction of
only microscopically visible adenomas in mice, 4-11 months of age, injected
with 05 mg. of this hydrocarbon into the lung (Rask-Nielsen, 1948), whereas no
grossly visible pulmonary adenomas were observed (Rask-Nielsen, 1950b).
To sum up, subcutaneous injection of benzpyrsne, dibenzanthracene, and
methylcholanthrene failed to induce remote tumours in Street mice, whereas
corresponding injections of 9:10-dimethyl-1:2-benzanthracene accelerated the
spontaneous development of leukaemia, pulmonary adenoma and granulosa-cell
tumour, but not the spontaneous development of mammary carcinoma, sub-
cutaneous, or cutaneous growths.
SUMMARY.
Subcutaneous injection of 0 5 mg. of benzpyrene, dibenzanthracene, methyl-
cholanthrene, and 9:10-dimethyl-1:2-benzanthracene into the flank of strain
Street mice induced local spindle-cell sarcoma in 27 per cent, 50 per cent, 39 per
cent and 12 per cent; and squamous-cell carcinoma in 6 per cent, 0 per cent, 7
per cent and 0-8 per cent respectively. Injection of the same hydrocarbons into
the mammary region induced spindle-cell sarcoma in 4 per cent, 22 per cent,
37 per cent and 8'3 per cent and squamous-cell carcinoma in 2 per cent, 2 per
cent, 22 per cent and 2-4 per cent respectively. Local mammary carcinoma was
not induced.
Leukaemia developed following subcutaneous injection into the flank and into
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the mammary region of benzpyrene, dibenzanthracene, methylcholanthrene and
9:10-dimethyl-1:2-benzanthracene in 6-7 per cent, 1-2 per cent, 0 per cent and
20A4 per cent respectively. The latent period was decreased only following
injection of 9:10-dimethyl-1:2-benzanthracene. The development of pulmonary
adenoma was not affected by injection of benzpyrene or dibenzanthracene,
whereas injection of methylcholanthrene and 9:10-dimethyl-1:2-benzanthracene
appears to have decreased the latent period of this growth.
Ovarian granulosa-cell tumours were noted in 2-5 per cent of mice following
injection of 9:10-dimethyl-1:2-benzanthracene, whereas the other three hydro-
carbons failed to accelerate the development ofthis growth.
The findings are discussed. The powerful remote, especially leukaemogenic,
effect of 9:10-dimethyl-1:2-benzanthracene is presumed to be due to a more rapid
absorption of this hydrocarbon from the subcutaneous tissue.
The investigations have been supported by grants from Anders Hasselbalch's
Leukaemia Fund, King Christian Xth's Fund, Jane Coffin Childs' Memorial Fund
for Medical Research, the Anna Fuller Fund, the National Advisory Cancer
Council of the United States Public Health Service.
REFERENCES.
BONSER, G. M., AND ORR, J. W.-(1939) J. Path. Bact., 49, 171.
ENGELBRETH-HOL,m, J.-(1939) Folia haemat. Lpz., 63, 319.-(1941) CancerRes., 1, 109.
Idem AND LEFkVRE, H.-(1941) Ibid., 1, 102.
ESMARcH, O.-(1940a) Actapath. microbiol. scand., 17, 9.-(1940b) 'StudieroverMethyl-
cholanthren og dets kraeftfremkaldende Virkning paa Mus.' Copenhagen.
GREENSTEIN, J. P.-(1947) 'Biochemistry of Cancer.' New York (Acad. Press).
KIRSCHBAUM, A., AND STRONG, L. C.-(1942) Cancer Res., 2, 841.
Iidem AND GARDNER, W. U.-(1940) Proc. Soc. exp. Biol., N.Y., 45, 287.
Idem, WTLLTAMS, W. L., AND BITTNER, J. J.-(1946) Cancer Res., 6, 354.
LAW, L. W.-(1941) Ibid., 1, 564.
LEFPVRE, H.-(1945) 'Acceleration of the Development of Spontaneous Tumours in
Mice.' Copenhagen.
LEITER, J., AND SHEAR, M. J.-(1943) J. nat. Cancer Inst., 3, 455.
MCENDY, D. P., BOON, M. C., AND FuRTH, J.-(1942) Ibid., 3, 227.
MIDER, G. B., AND MORTON, J. J.-(1939a) Proc. Soc. exp. Biol., N.Y., 42, 583.-(1939b)
Amer. J. Cancer, 37, 355.
MORTON, J. J., AND MIDER, G. B.-(1941) Cancer Res., 1, 95.
RASK-NIELSEN, R.-(1948) Acta path. microbiol. scand., Suppl. 78. (1949) Brit. J.
Cancer, 3, 549.-(1950a) Ibid., 4, 108.-(1950b) Ibid., 4, 117.
SHEAR, M. J.-(1938) Amer. J. Cancer, 33, 499.
STRONG, L. C.-(1945) Proc. Soc. exp. Biol., N.Y., 59, 217.
Idem AND SMITH, G. M.-(1939) Yale J. Biol. Med., 11, 589.
Idem AND WILLAMS, W. L.-(1941) Cancer Res., 1, 886.